Comunicati.net - Comunicati pubblicati - Editoria Comunicati.net - Comunicati pubblicati - Editoria Mon, 19 Aug 2019 19:07:59 +0200 Zend_Feed_Writer 1.12.20 (http://framework.zend.com) http://comunicati.net/comunicati/aziende/editoria/1 Global Surgical Imaging Market to reach a market size of $1.7 billion by 2025- KBV Research Fri, 16 Aug 2019 14:25:15 +0200 http://comunicati.net/comunicati/aziende/editoria/590096.html http://comunicati.net/comunicati/aziende/editoria/590096.html KBV Research KBV Research

According to a new report Global Surgical Imaging Market, published by KBV research, The Global Surgical Imaging Market size is expected to reach $1.7 billion by 2025, rising at a market growth of 5.4% CAGR during the forecast period.

 

surgical-imaging-market.jpg

The Mobile C-Arm market dominated the Global Surgical Imaging Market by Modality Type in 2018, growing at a CAGR of 3.7 % during the forecast period. The Mini C-Arm market is expected to witness a CAGR of 6.7% during (2019-2025).

 

The North America market dominated the Global Image Intensifiers Market by Region in 2018, growing at a CAGR of 5.3 % during the forecast period. The Europe market is expected to witness a CAGR of 5.6% during (2019-2025). Additionally, The Asia Pacific market is expected to witness a CAGR of 7.4% during (2019-2025).

 

The Neurosurgery market dominated the Global Surgical Imaging Market by Application in 2018, growing at a CAGR of 6.1 % during the forecast period. The Orthopaedic & Trauma Surgery market is expected to witness highest CAGR of 4% during (2019-2025).

 

Full Report: https://www.kbvresearch.com/surgical-imaging-market/

 

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of General Electric (GE), Genoray Co., Ltd., Siemens AG, Hologic, Inc., Koninklijke Philips N.V., Whale Imaging, Inc., Ziehm Imaging GmbH, Canon, Inc., Allengers Medical Systems Limited and Medtronic Plc.

 

Global Surgical Imaging Market Segmentation

 

By Modality Type

Mobile C-Arm

Mini C-Arm

Others

 

By Technology

Flat Panel Detectors

Image Intensifiers

 

By Application

Neurosurgery

Orthopaedic & Trauma Surgery

Cardiac & Vascular Surgery

General Surgery

Other Surgery

 

By Geography

 

North America

US

Canada

Mexico

Rest of North America

 

Europe

Germany

UK

France

Russia

Spain

Italy

Rest of Europe

 

Asia Pacific

China

Japan

India

South Korea

Singapore

Malaysia

Rest of Asia Pacific

 

LAMEA

Brazil

Argentina

UAE

Saudi Arabia

South Africa

Nigeria

Rest of LAMEA

 

Companies Profiled

General Electric (GE)

Genoray Co., Ltd.

Siemens AG

Hologic, Inc.

Koninklijke Philips N.V.

Whale Imaging, Inc.

Ziehm Imaging GmbH

Canon, Inc.

Allengers Medical Systems Limited

Medtronic Plc.

 

Surgical Imaging Market Related Reports:

North America Market

Europe Market

Asia Pacific Market

LAMEA Market

 

]]>
Knee Cartilage Repair Market Report with Respect to the Segments Based on Type and End-User Fri, 16 Aug 2019 10:00:04 +0200 http://comunicati.net/comunicati/aziende/editoria/589946.html http://comunicati.net/comunicati/aziende/editoria/589946.html Researcher Researcher The global knee cartilage repair market was valued at approximately US$ 4.0 Bn in 2017. It is projected to expand at a cumulative annual growth rate (CAGR) of 6% from 2018 to 2026, according to a new report published by Transparency Market Research (TMR) titled ‘Knee Cartilage Repair Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.’ The report suggests that an increase in the number of bone and joint injuries, enhancement in technology, and rise in awareness about health care are expected to propel the knee cartilage repair market in the near future. Additionally, increase in concerns about sports injuries and arthritis-related diseases is anticipated to drive the global market. North America and Europe are projected to dominate the global market, owing to an increase in orthopedic procedures, rise in incidence of obesity, and introduction of technologically advanced products in these regions. The market in Asia Pacific is projected to expand at a prominent CAGR between 2018 and 2026. This is due to increased spending on public health care systems, significant rise in the geriatric population, and increase in adoption of sports activities among the younger generation. The knee cartilage repair market in Latin America is likely to expand at a moderate growth rate during the forecast period.

knee cartilage repair industry

Request a PDF Sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4481

Rise in the number of orthopedic surgeries and usage of different implant materials for knee surgery are anticipated to fuel the global market

The global knee cartilage repair market is projected to be driven by the rise in number of orthopedic surgeries and utilization of different implant materials during knee surgery streamlines the day to day work flow for differently abled or arthritis patients. Knee cartilage repair devices such as implants provide several features and benefits, such as patient easy mobility, which can be practiced by surgeons and physicians for the differently abled patients. Key players offering knee cartilage repair are developing value added features, such as biological or synthetics material features. These features help reduce the overall operating costs and improve effectiveness and efficiency of physiotherapy practiced on the knees. Companies are focusing on the development of biological solutions for knee surgery-related issues. The market for biological or synthetic implant material is expanding significantly, worldwide, due to high success rate of the surgery, less post implantation infection, and high preference for the product by surgeons. Moreover, most innovative synthetic implants are not easily degraded in the body and provide efficiency during body mobility. BioPoly (material with its interpenetrated HA molecules), MaioRegen (Bio-mimetic, biointegratable and resorbable) are few examples of knee cartilage materials that save the operational time of physicians or surgeons and help improve the performance of patients post-surgery.

Arthroscopic chondroplasty is projected to be a highly lucrative procedure

Arthroscopic chondroplasty involves the repair of a small area of damaged cartilage in the knee. During this procedure, the damaged tissue is removed, allowing healthy cartilage to grow in its place. Meniscal tears are the most common reason for arthroscopic chondroplasty. The damage caused through meniscal tears is trimmed and smoothened down through chondroplasty. Faster recovery time of arthroscopic chondroplasty, as compared to other traditional methods of open knee surgeries, is likely to drive the segment during the forecast period. Technology-based knee cartilage repair are priced on a perpetual license model and are less expensive than other orthopedic surgeries. Arthroscopic chondroplasty enables users to practice low frequency clinical applications, allow healing of extreme pain in musculoskeletal structures, and provide assurance of 90% recovery by physicians. These factors are likely to propel the arthroscopic chondroplasty segment during the forecast period. It is preferred due to its low cost and outpatient procedure, which is used to repair a small area of damaged cartilage in the knee. Furthermore, arthroscopic chondroplasty based on technology facilitates pain relief and increases the range of motion and muscular strength among patients who have a knee injury.

Cell-based cartilage resurfacing application of knee cartilage repair is expected to boost the market

The cell-based cartilage resurfacing segment is anticipated to expand at a higher CAGR during the forecast period. Factors attributed to the higher CAGR of the cell-based cartilage resurfacing segment include rise in the incidence of orthopedic surgeries, increase in the prevalence of damage articular cartilage and arthritis among the global population, and rise in demand for minimally invasive orthopedic surgeries from physicians and patients. Moreover, cell therapy and tissue engineering techniques are positively influencing orthopedic patients, which in turn is likely to fuel the demand for cell-based cartilage resurfacing application during the forecast period. Reimbursement and Medicare benefits available to patients for the treatment of knee arthritis and musculoskeletal disorders have contributed to the major share held by the cell-based cartilage resurfacing segment.

Hospitals segment dominates the market and is estimated to expand at a rapid CAGR during the forecast period

In terms of end-user, the hospitals segment accounted for a leading share of the global knee cartilage repair market. The market share held by the segment is estimated to increase by the end of 2026. The hospitals segment is anticipated to expand at a CAGR of more than 6% during the forecast period. Rise in the availability of specialized pain management services, increase in the footfall of orthopedic patients in hospitals, and adoption of digital platforms for the marketing of the pain management practices have led to the prominent share held by the hospitals segment in the global knee cartilage repair market. Increase in number of multinational hospital chains and high digitization budgets are likely to drive the hospitals segment during the forecast period. High prevalence and incidence rates of bone injuries and arthritis and increase in number of cases of knee fractures and damaged articular cartilage among the global population have led to an increase in patient flow to hospitals. These factors are expected to fuel the hospitals segment at a significant pace between 2018 and 2026.

Asia Pacific offers considerable business development opportunity

North America and Europe accounted for a key share of the global knee cartilage repair market in 2017. They are likely to gain market share by the end of 2026. High rate of adoption of digital platforms for pain management, high spending on health care facility, and government initiatives to promote minimal invasive surgery techniques have contributed to the leading share held by these regions in the global knee cartilage repair market. Asia Pacific is projected to be a highly attractive market for knee cartilage repair, and the region is likely to exhibit a high attractiveness index. The market in Asia Pacific is projected to expand at a high CAGR of more than 6% during the forecast period, due to the presence of a large number of orthopedic hospitals & clinics in emerging countries, such as India and China, well-established health care facilities, and significant rise in geriatric population in countries such as Japan, Australia & New Zealand, Malaysia, and Singapore. The market in Latin America is expected to expand at a moderate pace during the forecast period.

Key Trend of research and development among leading players to increase geographic presence

The report also provides profiles of leading players operating in global knee cartilage repair market. DePuy Synthes, Zimmer Biomet, Stryker Corporation, Smith & Nephew plc, and B. Braun Melsungen AG are some leading players operating in the global knee cartilage repair market. They account for a significant share of the global market. Companies operating in the knee cartilage repair industry are aiming to increase their geographic presence by means of strategic acquisitions and collaborations with leading players in their respective domains and geographies. In October 2014, Zimmer Biomet Holdings, Inc. acquired the business of Massachusetts-based ETEX Holdings, Inc., which offers bone void filler technologies for early stages of joint disease. The acquisition would enhance Zimmer's biologics portfolio of differentiated treatments through the addition of ETEX's Beta-bsm (injectable), CarriGen, EquivaBone (including DBM), and Gamma-bsm (putty) bone void filler products. Other prominent players operating in the global knee cartilage repair include Histogenics Corporation, ISTO Technologies, Inc., MEDIPOST Co. Ltd., Osiris Therapeutics, Inc., TiGenix NV, and Vericel Corporation.

Request a PDF of Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4481

]]>
Report on Single-use Bioprocessing Systems Market has been Segmented Based on Type, End-User, and Region Fri, 16 Aug 2019 09:55:07 +0200 http://comunicati.net/comunicati/aziende/editoria/589943.html http://comunicati.net/comunicati/aziende/editoria/589943.html Researcher Researcher Transparency Market Research (TMR) (www.transparencymarketresearch.com) has published a new report titled, “Single-use Bioprocessing Systems Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global single-use bioprocessing systems market was valued at US$ 2791.4 Mn in 2017 and is anticipated to expand at a CAGR of 11.4% from 2018 to 2026 to reach value of US$ 7,259.9 Mn in 2026. Growth of the pharmaceutical industry, rise in government initiatives, increase in health care expenditure, new product approvals, and growth in patient population are projected to augment the global market from 2018 to 2026.

The single-use bioprocessing systems market has progressed from being in a nascent phase in the 1990s to a thriving market in the recent years due to rapid adoption and demand for single-use bioprocessing systems from large as well as small, niche biopharmaceutical companies. CROs and CMOs which have smaller facility design and operate under stringent deadlines for their customers are also expected to show significant demand for single-use systems during the forecast period. Demand for single-use bioprocessing systems, particularly bioprocessing bags, single-use filters, and bioreactors, has been driven by pressure to surmount competition as well as decrease the disease burden by bringing cheaper drugs to the market. Since single-use technologies can be installed easily in a period of 6-18 months and require low capital costs at the time of installation, the time needed to market critically important biologics, such as, vaccines and monoclonal antibodies used in the treatment of cancer and infectious diseases is significantly reduced, and so does the cost of producing the product. Such advantages are likely to boost the single-use bioprocessing systems market in regions such as Asia Pacific and Middle East & Africa, where there is a substantial population requiring treatment for autoimmune diseases and cancers at an affordable cost. Moreover, preventive needs such as vaccination are all the more crucial in developing countries, where the risk of getting affected by infectious diseases is higher compared to that in the developed world.

single use bio processing systems industry

Request a PDF Sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3753

Increase in Demand for Biopharmaceuticals and Outsourcing of Products

Growth in aging population across the world is pushing the proportion of patients suffering from various infections and diseases. According to research findings by the World Health Organization (WHO) in 2016, the number of people aged 60 years and above will reach 2.5 billion approximately by the end of 2050. More than 25% of the world’s population will be over 65 years of age. Geriatric people are more prone to diseases such as hypertension, chronic kidney diseases, diabetes, cardiovascular diseases, cancer, etc., as their immunity becomes weak with growing age. Thus, it increases the demand for medical supply and services in biopharmaceuticals among patients.  This, in turn, leads to the use of bioprocessing systems for better process efficiency and throughput. It also gives an edge over easy and better regulatory compliance process. Additionally, rise in outsourcing of manufacturing activities to CMOs, CROs, and CDMOs is set to propel the single-use bioprocessing industry, as increasing number of CMOs that have small flexible facilities are now beginning to rely on single-use equipment in their process value chain. As such, these factors help drive the global single use bioprocessing systems market.

Customization of Single-use Products as per Customer Preference

An important driver of the single-use bioprocessing systems market is the provision of customization that these systems provide to the customers. Bioreactors, bioprocess, single-use bags containers are all open to customer specific requirements, depending on the type of application. Precisely, these systems provide flexibility to the customer, which is not the case with capital equipment. Small or medium-sized manufacturers can buy and customize their products. For example, bags can be customized right from 50 ml to 2500 L in size. Thermo Fisher Scientific believes most of its business in North America is driven by custom requests within and around its plant location.

Help in Purification and Downstream Processing

Single-use filters are a highly useful purchase for bioprocessing operations as they aid in the most critical separation and purification step during downstream processing as well as filtration of debris and contaminants during upstream processing. Single-use tubing assemblies and other consumables, such as, connectors and clamps are crucial to link processes in the production chain, and thus, their market is anticipated to remain strong in line with the sale of bioprocessing equipment. Overall the single-use bioprocessing systems market is projected to witness strong growth as it caters to a broad base of consumers — those willing to opt for hybrid bio-manufacturing facility set-ups (stainless steel & single-use) as well as for fully single-use facility set-ups. Moreover, presence of vendors with access to technological expertise is likely to further propel the growth of the market.

Technical Difficulties

Extractables are chemical species that migrate from packaging or container materials into the contents when exposed to certain solvents in exaggerated temperature and time conditions. Leachables are chemical species that make their way into the product under normal application conditions. It is imperative that single-use products are devoid of extractables and leachables as these have the potential to interact with a drug at multiple stages during development and production, which could impact efficacy, safety, and quality of the final product. Top manufacturers check such risks associated with extractables or leachables; however, these could still remain a potential risk, especially if purchased from local unregulated manufacturers. Single-use systems also have other technical limitations including, difficulty in scaling-up to large volumes and potential risk of puncture and tearing of the plastic under high-stress conditions. Thus, the aforementioned factors are anticipated to restrain the growth of the single-use bioprocessing systems market during the forecast period.

Key companies profiled in the report include Merck KGaA (Merck Millipore), Thermo Fisher Scientific, Sartorius AG, Danaher Corporation (Pall Corporation), Eppendorf AG, GE Healthcare, PBS Biotech, Inc., Meissner Filtration Products, Inc., Finesse Solutions, Sentinel Process Solutions, and Saint-Gobain .

Request a PDF of Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3753

]]>
Global Cancer Cachexia Market: Key Segments and Regional Outlook Fri, 16 Aug 2019 09:50:28 +0200 http://comunicati.net/comunicati/aziende/editoria/589939.html http://comunicati.net/comunicati/aziende/editoria/589939.html Researcher Researcher The global cancer cachexia market demonstrates a considerably high competition among the leading players, finds a new research report by Transparency Market Research (TMR). The key vendors of cancer cachexia treatment solutions, globally, are actively involving in partnerships, mergers, and acquisitions with clinical trial companies in a bid to strengthen their product portfolios. They are likely to focus more on technological upgrades and introducing new therapeutics based on appetite stimulation mechanism of action for the treatment of cancer cachexia in the near future, as it will be the new trend in this market. The key participants operating in this market are Æterna Zentaris Inc., Aphios Corp., Alder BioPharmaceuticals Inc., Eli Lilly and Co., Helsinn Group, GTx Inc., Merck & Co. Inc., Bristol-Myers Squibb Co., Novartis AG, and XBiotech Inc., states the research report.

According to the research report, the global market for cancer cachexia was worth US$1.63 bn in 2016. Research analyst at TMR expect the opportunity in this market to rise at a CAGR of 4.90% during the period from 2017 to 2025 and reach a value of US$2.51 bn by the end of the period of the forecast. Among the therapeutics available for the treatment of cancer cachexia, the demand for progestogens is comparatively higher and is expected to remain so over the next few years, thanks to their efficiency. Regionally, the market is led by North America. Researchers project this regional market to continue on the top in the near future on account of the rising awareness among people regarding cancer supportive care, notes the market study.

cancer-cachexia-market.jpg

Request for Sample Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=15482

Increasing Prevalence of Cancer Cachexia to Offer Lucrative Opportunities to Market Players

The increasing prevalence of cachexia, especially in industrialized regions, such as North America, Europe, and Japan, is the main factor behind the significant growth of the market for cancer cachexia, worldwide. According to an estimation, currently, cachexia affects around nine million patients, globally, which is round about 1% of overall patient-pool across the world. This factor is expected to create more opportunities for existing participants and players, looking to enter the market over the next few years.

The strong product pipeline is another important factor that will support the growth of this market in the near future. “With a promising clinical pipeline and imminent regulatory approvals, the global market for cancer cachexia is likely to report a substantial growth in the years to come, states the author of the research study.

Stringent Regulatory Requirements May Hamper Growth

Although the worldwide market for cancer cachexia points towards a thriving future; its growth trajectory will not be smooth enough. The stringent regulatory requirements and the long procedure for FDA approval may dissuade the manufacturers of cancer cachexia drugs from investing in this market over the forthcoming years, which, in turn, will impede the growth of this market in the long run, states the research report.

Request a PDF of Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=15482

]]>
Global Spine Surgery Products Market: Key Segments and Regional Outlook Fri, 16 Aug 2019 09:44:49 +0200 http://comunicati.net/comunicati/aziende/editoria/589938.html http://comunicati.net/comunicati/aziende/editoria/589938.html Researcher Researcher The global spine surgery products market is expected in a report by Transparency Market Research (TMR) to find companies focusing on mergers and acquisitions, expansion of regional footprint, and diversification of product portfolio to stay in a strong position. Presence of several high-impact players could raise the level of competition in the market. New aspirants are foreseen to come across favorable opportunities for entering the market. Looking at the intensifying nature of competition, players are observed to invest more in research and development to stay afloat when operating in the market. Furthermore, there could be a high focus on innovation.

TMR prophesies the global spine surgery products market to rise at a 5.8% CAGR during the forecast period 2017-2025 to touch a valuation of US$16.7 bn by the final forecast year. In 2016, the market was valued at a US$10.2 bn. In the same year, fusion product secured a higher share of the market, and is forecasted to continue leading the market in the coming years. By region, North America could be in charge of the market with regard to revenue generation.

spine surgery products market

Request for Sample Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=37748

Growing Incidence of Accidents that Cause Spinal Injuries Surges Demand

The world spine surgery products market is foretold to become popular with rising accidental cases involving spinal injuries among young adults. Since geriatrics are more likely to face spinal disorders and undergo spinal surgeries, increase in their population could be another factor helping the market to take the center stage. In the near future, the market is envisioned to accelerate growth on the back of spinal surgery recommendations given to patients and several technological developments in the field. For instance, minimally invasive surgeries are on the rise in North America for serious disorders such as adolescent idiopathic scoliosis (AIS).

Number of Products Failing in Clinical Trials could Delay Growth in Market

Seasoned analysts project the international spine surgery products market to grow well in the foreseeable future. However, there could be a few market restraints troubling growth during the course of the forecast period. For instance, lengthy product approvals and clinical trial failures of several spinal surgery products are envisaged to cut short the demand in the market.

Nonetheless, players could cash in on some lucrative prospects still available in the international spine surgery products market. Improved healthcare infrastructure in Canada, promising reimbursement policies, and increased adoption for diagnosing and treating different types of spinal disorders are anticipated to create a wealth of opportunities in North America. In Europe, expansion of insurance coverage and rising prevalence of chronic diseases leading to increasing number of spinal surgeries could improve demand in the market.

Request for Customization in Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=37748

]]>
Vaccines Market: Key Market Segments, Regional Analysis, Pricing Assessment Fri, 16 Aug 2019 09:41:51 +0200 http://comunicati.net/comunicati/aziende/editoria/589937.html http://comunicati.net/comunicati/aziende/editoria/589937.html Researcher Researcher The demand within the global market for vaccines has been rising on account of advancements in the field of medical therapy and disease prevention, finds Transparency Market Research (TMR). There is a high probability of new vendors emerging in the global vaccines market in the years to come. The historic trends have been suggestive of the opportunities that have aided market growth in recent times. The leading vendors in the global vaccines market have engaged in core research and development in order to earn increased revenues. Furthermore, these vendors are projected to invest in new vaccination lines to elevate their standards of production.

The competition in the global market for vaccines is expected to intensify in the years to come. This is because a large number of established players are moving neck and neck in the quest to develop more effective vaccines. The competition in the global vaccines market has further escalated on account of the emergence of newbie vendors in the global vaccines market. There is a heavy possibility of strategic alliances being formed in the global vaccines market. Some of the key players in the global vaccines market are CSL Ltd, Janssen Pharmaceutical Company, GlaxoSmithKline plc., Pfizer, Inc., Mitsubishi Tanabe Pharma Corporation, and Sanofi Pasteur SA.

Transparency Market Research (TMR) predicts that the global market for vaccines would expand at a healthy CAGR of 6.0% over the period between 2017 and 2025. Furthermore, the cumulative value of the global vaccines market is projected to reach US$ 48.0 Bn by 2025-end, rising up from a value of US$ 28.0 Bn in 2016. On the basis of vaccine type, the market for toxoid vaccines is expected to expand in the years to come. Based on geography, the market for vaccines in Europe is projected to accumulate humongous revenues in the years to come.
global vaccines market

Request a PDF Sample https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=21

Availability of Vaccines for Kids to Propels

The global market for vaccines caters to the masses of all age groups, including children. The need to vaccinate children in order to prevent them from serious diseases is being felt across the world. Hence, the global vaccines market is projected to expand alongside advancements in the field of disease care and paediatrics. Furthermore, the market for vaccines has also expanded on account of the growth of new and advanced facilities across medical facilities such as healthcare centers and hospitals. Doctors and medical practitioners recommend all essential vaccines for people of various age groups which in turn pushes market growth.

Emergence of New Selling Points to Aid Market Growth

The global market for vaccines has been expanding alongside increase in the number of distribution channels for vaccines. The popularity of institutional sales for the purposeof vaccination has created stellar opportunities for growth within the global market. Moreover, hospitals now have dedicated sections for vaccination and treatment which has in turn propelled market demand. Medication and injective vaccines are also available across retail pharmacies, and this another key consideration from the perspective of market growth. The revenue index of the global vaccines market is projected to reach new volumes in the years to come.

Request for Customization in Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=21

]]>
Global Spirulina Market to reach a market size of $651 Million by 2025- KBV Research Wed, 14 Aug 2019 15:14:03 +0200 http://comunicati.net/comunicati/aziende/editoria/589806.html http://comunicati.net/comunicati/aziende/editoria/589806.html KBV Research KBV Research

According to a new report Global Spirulina Market, published by KBV Research, The Global Spirulina Market size is expected to reach $651 Million by 2025, rising at a market growth of 10.6% CAGR during the forecast period.

 

spirulina-market.jpg

The North America market dominated the Global Arthrospira Platensis Market by Region in 2018, growing at a CAGR of 8.5 % during the forecast period. The Europe market is expected to witness a CAGR of 8.7% during (2019-2025). Additionally, The Asia Pacific market is expected to witness a CAGR of 10.6% during (2019-2025).

 

The Nutraceuticals market dominated the Global Spirulina Market by Application in 2018, growing at a CAGR of 9.7 % during the forecast period. The Cosmetics market is expected to witness a CAGR of 12.8% during (2019-2025).

 

The Powder market dominated the Global Spirulina Market by Drug Formulation in 2018, growing at a CAGR of 9.9 % during the forecast period. The Tablet & Capsule market is expected to witness highest CAGR of 10.1% during (2019-2025).

 

Full Report: https://www.kbvresearch.com/spirulina-market/

 

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Cyanotech Corporation, DIC Corporation, Chr. Hansen Holding A/S, Algenol, LLC, Prolgae Spirulina Supplies Pvt. Ltd., Sensient Technologies Corporation, DDW, Inc., GNC Holdings, Inc., NOW Foods, Inc. and Sunrise Nutrachem Group Co. Ltd.

 

Global Spirulina Market Segmentation

 

By Type

Arthrospira Platensis

Arthrospira Maxima

 

By Application

Nutraceuticals

Cosmetics

Food and Beverages

Animal Feed

Other Applications

 

By Drug Formulation

Powder

Tablet & Capsule

Liquid

Granule & Gelling Agent

 

By Geography

 

North America

US

Canada

Mexico

Rest of North America

 

Europe

Germany

UK

France

Russia

Spain

Italy

Rest of Europe

 

Asia Pacific

China

Japan

India

South Korea

Singapore

Malaysia

Rest of Asia Pacific

 

LAMEA

Brazil

Argentina

UAE

Saudi Arabia

South Africa

Nigeria

Rest of LAMEA

 

Companies Profiled

Cyanotech Corporation

DIC Corporation

Chr. Hansen Holding A/S

Algenol, LLC

Prolgae Spirulina Supplies Pvt. Ltd.

Sensient Technologies Corporation

DDW, Inc.

GNC Holdings, Inc.

NOW Foods, Inc.

Sunrise Nutrachem Group Co. Ltd.

 

Spirulina Market Related Reports:

North America Market

Europe Market

Asia Pacific Market

LAMEA Market

 

]]>
TMR’s Recent Publication includes an Extensive Analysis on the Pouchitis Treatment Market Tue, 13 Aug 2019 16:27:41 +0200 http://comunicati.net/comunicati/aziende/editoria/589492.html http://comunicati.net/comunicati/aziende/editoria/589492.html Researcher Researcher The global Pouchitis Treatment market rides on the back of technology. As consumer focus shifts from access to comfort, players in the market for Pouchitis Treatment are looking at new opportunities to capitalize on the potential. This exclusive report from Transparency Market Research will take you through an extensive analysis of every aspect in the Pouchitis Treatment market that is critical for defining your success strategy. It offers prudent information on market’s under currents, trends that will open new doors, factors that will remain important, challenges that need to be overcome, prevailing competition in the market, and the geographical landscape.

Based on a tested and proven research methodology, our research analysts bring to you fact-checked information. Besides presenting the current market figures, our analysts provide you with accurate forecasts that can be the game-changer for your winning strategies for tomorrow. On the other hand, our reports also offer tailor-made insights. Further, our reports are packed with experts’ viewpoints which are transcribed from interviews conducted by our analysts.

Request for Customization in Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=42062

For every market, information on leading players can be the difference between success and failure, be it a prominent brand or not. Our reports cover every significant players in the global Pouchitis Treatment market providing information about the company profile, products, winning strategies and market revenues. Not just that, TMR also provides information on the competitive landscape, helping you understand what impacted in one company being the market leader and others not. It also explains on the companies’ imperatives that define their success in the global market for Continuous Positive Airway Pressure Humidifiers.

Healthcare, unlike most industries, is typical of the region. Humans have multiple races and hence their genetic makeups are different. As a result, one condition has different impacts depending on the region. Therefore, information on how consumer requirements are different in regional landscape of the global Pouchitis Treatment market is provided here in the report. Further, the economic capabilities of a country have a huge impact on healthcare infrastructure. TMR’s report analysis the current economic scenario and also brings to you information on affordability during the coming years.

From market share to region-specific strategies, the report covers it all. At the same time, players in the Pouchitis Treatment market who are looking to expand might want to assess the potential of a prospective region. Our reports can provide you with custom-made insights for specific regions in the global Pouchitis Treatment market. The geographical analysis also covers regions-specific factors that could turn out to be hurdle for growth in the coming years.

Request for Discount @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=42062

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/

]]>
Major Players Operating in the Nitinol Stents Market Tue, 13 Aug 2019 16:24:08 +0200 http://comunicati.net/comunicati/aziende/editoria/589489.html http://comunicati.net/comunicati/aziende/editoria/589489.html Researcher Researcher The global Nitinol Stents market rides on the back of technology. As consumer focus shifts from access to comfort, players in the market for Nitinol Stents are looking at new opportunities to capitalize on the potential. This exclusive report from Transparency Market Research will take you through an extensive analysis of every aspect in the Nitinol Stents market that is critical for defining your success strategy. It offers prudent information on market’s under currents, trends that will open new doors, factors that will remain important, challenges that need to be overcome, prevailing competition in the market, and the geographical landscape.

Based on a tested and proven research methodology, our research analysts bring to you fact-checked information. Besides presenting the current market figures, our analysts provide you with accurate forecasts that can be the game-changer for your winning strategies for tomorrow. On the other hand, our reports also offer tailor-made insights. Further, our reports are packed with experts’ viewpoints which are transcribed from interviews conducted by our analysts.

Request for Customization in Report @https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=41312

For every market, information on leading players can be the difference between success and failure, be it a prominent brand or not. Our reports cover every significant players in the global Nitinol Stents market providing information about the company profile, products, winning strategies and market revenues. Not just that, TMR also provides information on the competitive landscape, helping you understand what impacted in one company being the market leader and others not. It also explains on the companies’ imperatives that define their success in the global market for Continuous Positive Airway Pressure Humidifiers.

Healthcare, unlike most industries, is typical of the region. Humans have multiple races and hence their genetic makeups are different. As a result, one condition has different impacts depending on the region. Therefore, information on how consumer requirements are different in regional landscape of the global Nitinol Stents market is provided here in the report. Further, the economic capabilities of a country have a huge impact on healthcare infrastructure. TMR’s report analysis the current economic scenario and also brings to you information on affordability during the coming years.

From market share to region-specific strategies, the report covers it all. At the same time, players in the Nitinol Stents market who are looking to expand might want to assess the potential of a prospective region. Our reports can provide you with custom-made insights for specific regions in the global Nitinol Stents market. The geographical analysis also covers regions-specific factors that could turn out to be hurdle for growth in the coming years.

Request for Discount @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=41312

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/

]]>
Top Key Players Analysis Report in the Anti-anginal Drugs Market Tue, 13 Aug 2019 16:22:16 +0200 http://comunicati.net/comunicati/aziende/editoria/589487.html http://comunicati.net/comunicati/aziende/editoria/589487.html Researcher Researcher The global Anti-anginal Drugs market rides on the back of technology. As consumer focus shifts from access to comfort, players in the market for Anti-anginal Drugs are looking at new opportunities to capitalize on the potential. This exclusive report from Transparency Market Research will take you through an extensive analysis of every aspect in the Anti-anginal Drugs market that is critical for defining your success strategy. It offers prudent information on market’s under currents, trends that will open new doors, factors that will remain important, challenges that need to be overcome, prevailing competition in the market, and the geographical landscape.

Based on a tested and proven research methodology, our research analysts bring to you fact-checked information. Besides presenting the current market figures, our analysts provide you with accurate forecasts that can be the game-changer for your winning strategies for tomorrow. On the other hand, our reports also offer tailor-made insights. Further, our reports are packed with experts’ viewpoints which are transcribed from interviews conducted by our analysts.

Request for Customization in Report @https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=42011

For every market, information on leading players can be the difference between success and failure, be it a prominent brand or not. Our reports cover every significant players in the global Anti-anginal Drugs market providing information about the company profile, products, winning strategies and market revenues. Not just that, TMR also provides information on the competitive landscape, helping you understand what impacted in one company being the market leader and others not. It also explains on the companies’ imperatives that define their success in the global market for Continuous Positive Airway Pressure Humidifiers.

Healthcare, unlike most industries, is typical of the region. Humans have multiple races and hence their genetic makeups are different. As a result, one condition has different impacts depending on the region. Therefore, information on how consumer requirements are different in regional landscape of the global Anti-anginal Drugs market is provided here in the report. Further, the economic capabilities of a country have a huge impact on healthcare infrastructure. TMR’s report analysis the current economic scenario and also brings to you information on affordability during the coming years.

From market share to region-specific strategies, the report covers it all. At the same time, players in the Anti-anginal Drugs market who are looking to expand might want to assess the potential of a prospective region. Our reports can provide you with custom-made insights for specific regions in the global Anti-anginal Drugs market. The geographical analysis also covers regions-specific factors that could turn out to be hurdle for growth in the coming years.

Request for Discount @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=42011

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/

]]>
Key Industry Trends Bolstering Vascular Endothelial Growth Factor Inhibitors Market Growth Tue, 13 Aug 2019 16:13:25 +0200 http://comunicati.net/comunicati/aziende/editoria/589484.html http://comunicati.net/comunicati/aziende/editoria/589484.html Researcher Researcher The global Vascular Endothelial Growth Factor (VEGF) Inhibitors market rides on the back of technology. As consumer focus shifts from access to comfort, players in the market for Vascular Endothelial Growth Factor (VEGF) Inhibitors are looking at new opportunities to capitalize on the potential. This exclusive report from Transparency Market Research will take you through an extensive analysis of every aspect in the Vascular Endothelial Growth Factor (VEGF) Inhibitors market that is critical for defining your success strategy. It offers prudent information on market’s under currents, trends that will open new doors, factors that will remain important, challenges that need to be overcome, prevailing competition in the market, and the geographical landscape.

Based on a tested and proven research methodology, our research analysts bring to you fact-checked information. Besides presenting the current market figures, our analysts provide you with accurate forecasts that can be the game-changer for your winning strategies for tomorrow. On the other hand, our reports also offer tailor-made insights. Further, our reports are packed with experts’ viewpoints which are transcribed from interviews conducted by our analysts.

Request for Customization in Report @https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=42026

For every market, information on leading players can be the difference between success and failure, be it a prominent brand or not. Our reports cover every significant players in the global Vascular Endothelial Growth Factor (VEGF) Inhibitors market providing information about the company profile, products, winning strategies and market revenues. Not just that, TMR also provides information on the competitive landscape, helping you understand what impacted in one company being the market leader and others not. It also explains on the companies’ imperatives that define their success in the global market for Continuous Positive Airway Pressure Humidifiers.

Healthcare, unlike most industries, is typical of the region. Humans have multiple races and hence their genetic makeups are different. As a result, one condition has different impacts depending on the region. Therefore, information on how consumer requirements are different in regional landscape of the global Vascular Endothelial Growth Factor (VEGF) Inhibitors market is provided here in the report. Further, the economic capabilities of a country have a huge impact on healthcare infrastructure. TMR’s report analysis the current economic scenario and also brings to you information on affordability during the coming years.

From market share to region-specific strategies, the report covers it all. At the same time, players in the Vascular Endothelial Growth Factor (VEGF) Inhibitors market who are looking to expand might want to assess the potential of a prospective region. Our reports can provide you with custom-made insights for specific regions in the global Vascular Endothelial Growth Factor (VEGF) Inhibitors market. The geographical analysis also covers regions-specific factors that could turn out to be hurdle for growth in the coming years.

Request for Discount @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=42026

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/

]]>
Cardiovascular Ultrasound Imaging Systems Market Report with Respect to the Segments Based on Type and End-User Tue, 13 Aug 2019 16:10:54 +0200 http://comunicati.net/comunicati/aziende/editoria/589483.html http://comunicati.net/comunicati/aziende/editoria/589483.html Researcher Researcher The global Cardiovascular Ultrasound Imaging Systems market rides on the back of technology. As consumer focus shifts from access to comfort, players in the market for Cardiovascular Ultrasound Imaging Systems are looking at new opportunities to capitalize on the potential. This exclusive report from Transparency Market Research will take you through an extensive analysis of every aspect in the Cardiovascular Ultrasound Imaging Systems market that is critical for defining your success strategy. It offers prudent information on market’s under currents, trends that will open new doors, factors that will remain important, challenges that need to be overcome, prevailing competition in the market, and the geographical landscape.

Based on a tested and proven research methodology, our research analysts bring to you fact-checked information. Besides presenting the current market figures, our analysts provide you with accurate forecasts that can be the game-changer for your winning strategies for tomorrow. On the other hand, our reports also offer tailor-made insights. Further, our reports are packed with experts’ viewpoints which are transcribed from interviews conducted by our analysts.

Request for Customization in Report @https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=42101

For every market, information on leading players can be the difference between success and failure, be it a prominent brand or not. Our reports cover every significant players in the global Cardiovascular Ultrasound Imaging Systems market providing information about the company profile, products, winning strategies and market revenues. Not just that, TMR also provides information on the competitive landscape, helping you understand what impacted in one company being the market leader and others not. It also explains on the companies’ imperatives that define their success in the global market for Continuous Positive Airway Pressure Humidifiers.

Healthcare, unlike most industries, is typical of the region. Humans have multiple races and hence their genetic makeups are different. As a result, one condition has different impacts depending on the region. Therefore, information on how consumer requirements are different in regional landscape of the global Cardiovascular Ultrasound Imaging Systems market is provided here in the report. Further, the economic capabilities of a country have a huge impact on healthcare infrastructure. TMR’s report analysis the current economic scenario and also brings to you information on affordability during the coming years.

From market share to region-specific strategies, the report covers it all. At the same time, players in the Cardiovascular Ultrasound Imaging Systems market who are looking to expand might want to assess the potential of a prospective region. Our reports can provide you with custom-made insights for specific regions in the global Cardiovascular Ultrasound Imaging Systems market. The geographical analysis also covers regions-specific factors that could turn out to be hurdle for growth in the coming years.

Request for Discount @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=42101

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/

]]>
Demand Within the Global Market for Osteomalacia Drugs has been Rising Tue, 13 Aug 2019 16:08:47 +0200 http://comunicati.net/comunicati/aziende/editoria/589482.html http://comunicati.net/comunicati/aziende/editoria/589482.html Researcher Researcher The global  Osteomalacia Drugs market  rides on the back of technology. As consumer focus shifts from access to comfort, players in the market for osteomalacia Drugs are looking at new opportunities to capitalize on the potential. This exclusive report from Transparency Market Research will take you through an extensive analysis of every aspect in the Osteomalacia Drugs market that is critical for defining your success strategy. It offers prudent information on the market under currents, trends that will open new doors, factors that will remain important, challenges that need to be overcome, prevailing competition in the market, and the geographical landscape.

Based on a tested and proven research methodology, our research analysts bring to you fact-checked information. Besides presenting the current market figures, our analysts provide you with accurate forecasts that can be the game-changer for your winning strategies for tomorrow. On the other hand, our reports also offer tailor-made insights. Further, our reports are packed with experts’ viewpoints which are transcribed from interviews conducted by our analysts.

Request for Customization in Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=42143

For every market, information on leading players can be the difference between success and failure, be it a prominent brand or not. Our reports cover every significant players in the global Osteomalacia Drugs market providing information about the company profile, products, winning strategies and market revenues. Not just that, TMR also provides information on the competitive landscape, helping you understand what impacted in one company being the market leader and others not. It also explains on the companies’ imperatives that define their success in the global market for Continuous Positive Airway Pressure Humidifiers.

Healthcare, unlike most industries, is typical of the region. Humans have multiple races and hence their genetic makeups are different. As a result, one condition has different impacts depending on the region. Therefore, information on how consumer requirements are different in regional landscape of the global Osteomalacia Drugs market is provided here in the report. Further, the economic capabilities of a country have a huge impact on healthcare infrastructure. TMR’s report analysis the current economic scenario and also brings to you information on affordability during the coming years.

From market share to region-specific strategies, the report covers it all. At the same time, players in the Osteomalacia Drugs market who are looking to expand might want to assess the potential of a prospective region. Our reports can provide you with custom-made insights for specific regions in the global Osteomalacia Drugs market. The geographical analysis also covers regions-specific factors that could turn out to be hurdle for growth in the coming years.

Request for Discount @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=42143

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our Exclusive Blend of Quantitative Forecasting and Trends TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools to gather and analyze information.

Our data repository is updated and revised by a team of research experts, I know it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: + 1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:  sales@transparencymarketresearch.com
Website:  https: //www.transparencymarketresearch .com /

]]>
Solid Tumor Therapeutics Market - Top Manufacturers Report Tue, 13 Aug 2019 16:02:32 +0200 http://comunicati.net/comunicati/aziende/editoria/589479.html http://comunicati.net/comunicati/aziende/editoria/589479.html Researcher Researcher While suffering from cancer, solid tumors are generally formed due to an aggregation of the abnormal tissues. These tissues do not have any cyst or liquid. Such solid tumors can be of two types namely malignant and benign. It is tough to treat such solid tumors and it needs special attention and care from the healthcare professionals such as radiologists, oncologists, surgeon, and radiation specialists among others. Naturally, the majority of the solid tumors are treated with the help of surgery, chemotherapy, and/or radiotherapy. However, currently, getting rid of the solid tumor through surgery is the preferred treatment option. The solid tumor therapeutics is a type of pharmaceutical drugs that are designed to treat different types of cancers such as prostate cancer, cervical cancer, colorectal cancer, breast cancer, and lung cancer among others.

Identify the Key Factors that will drive your Company’s Growth. Request a Brochure of this Report here

Global Solid Tumor Therapeutics Market – Notable Developments

Some of the key developments in the global solid tumor therapeutics market are listed below:

  • In July 2019, GlaxoSmithKline PLC. announced that the company was successful in getting positive results from Phase 3 of its PRIMA research. This research is a placebo-controlled, double-blind, and randomized study of ZEJULA. It is a maintenance therapy for the patients suffering from the first line of ovarian cancer after undergoing platinum-based chemo. The research was concluded with a considerable statistic improvement in the development of the treatment of ovarian cancer in women regardless of the status of their biomarkers.
  • In June 2019, Roche announced that the Ministry of Health, Labor, and Welfare of Japan has given its approval to Rozlytrek®. Rozylytrek® is a new line of product launched by Roche that used in treating both pediatric and adult patients diagnosed with NTRK (neurotrophic tyrosine receptor kinase) fusion-positive advanced recurrent solid tumors. The medicine is the first solid tumor therapeutic drug approved by the Japanese ministry that tries to tackle the NTRK gene fusion. These NTRK gene fusions are identified across a broad range of solid tumors such as salivary gland, pancreatic, breast, thyroid, and lung among others.

Stuck in a Neck-to-Neck Competition with Other Brands? Request a Custom Report on “Solid Tumor Therapeutics Market” here

Global Solid Tumor Therapeutics Market – Drivers and Restraints

Some of the key driving factors for the growth of the global solid tumor therapeutics market are listed below:

  • Growth in product approvals: One of the primary reasons for the growth of the global market is the increasing number of product approvals in the market to treat different types of cancers such as prostate, pancreatic, and ovarian among others.
  • Government initiatives: Governments across the globe are investing heavily in healthcare research and development activities to discover products that will help in battling cancer. Solid tumor therapeutics is one such drug. In addition to this, governments are undertaking numerous initiatives to generate awareness about cancer and related therapies. This is also helping in fueling the growth of the market.

Global Solid Tumor Therapeutics Market – Regional Outlook

The global solid tumor therapeutics market is segmented into key geographical regions such as North America, Europe, South America, Asia Pacific, and the Middle East and Africa. Of these mentioned regions, the global solid tumor therapeutics market is currently dominated by the North America segment. It is expected that the region will continue its growth rate and market dominance over the course of the given forecast period of 2019 to 2027. Some of the reasons behind the growth of the North America market is the rising incidences of cancer, highly developed healthcare infrastructure, and increasing awareness among people.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Request Report Methodology @ https://www.transparencymarketresearch.com/solid-tumor-therapeutics-market.html#enquiry

]]>
Demand Within the Global Market for Nafarelin has been Rising on Account of Advancements in the Field of Healthcare Tue, 13 Aug 2019 15:59:55 +0200 http://comunicati.net/comunicati/aziende/editoria/589478.html http://comunicati.net/comunicati/aziende/editoria/589478.html Researcher Researcher The global nafarelin market is deriving its growth from the increasing number of girls and boys reaching the age puberty and the augmenting incidence of endometriosis in women across the world. Nafarelin, a gonadotropin-releasing hormone agonist (GnRH agonist), is mainly utilized to treat symptoms of endometriosis, such as menstrual cramps and pelvic pain. It is also useful in the treatment of central precocious puberty, that is, early puberty, in young girls and boys.

Apart from these, nafarelin finds extensive application in the treatment of uterine fibroids. It is also used to control the ovarian stimulation in in vitro fertilization (IVF) and as a part of transgender hormone therapy. All these result into a high demand for nafarelin, which leads to a thriving nafarelin market, globally.

In this research report, the global nafarelin market has been thoroughly evaluated, using quantitative and qualitative assessment techniques. It has estimated the market’s performance over the period from 2019 to 2027 on the basis of the key trends and market dynamics. It also offers precise evaluations of the main segments and each of the regional markets for nafarelin across the world.

Need an Overview of the Report on Nafarelin Market? Ask for the Brochure here

Global Nafarelin Market: Notable Developments

The global nafarelin market is beaming with success. Although the vendor landscape is in a consolidated state, thanks to the presence of only a few players, the competition among them is intense. Pfizer, Shanghai Soho-Yiming Pharmaceuticals, CPC Scientific, and Hangzhou Longshine Bio-Tech are the main participants in the worldwide nafarelin market.

Pfizer is the leading player in the global nafarelin market. It sells nafarelin under the brand name Synarel. With an established brand name and continued research in this field, the company is expected to remain on the top over the next few years. However, a few incidence of Synarel, or nafarelin acetate, causing serious side-effects in patients of endometriosis has reflected negatively on the reputation of Pfizer, which may slowdown the demand for Synarel in the near future. Other companies are also concentrating on research and development of their drugs in a bid to offer more efficient and less harmful medications to consumers.

Global Nafarelin Market Dynamics

Endometriosis has become a serious health issue among women across the world. If not treated in time, not just it causes extreme pain but also results into sterility in women. The high efficacy of nafarelin in treating endometriosis is leading to it high demand and resulting in a tremendous rise in the global nafarelin market. However, nafarelin treat endometriosis by stopping the release of hormones made by ovaries, which causes lowered level of estrogen that leads to premature menopause. This, in turn, minimizes the chances of conceiving and causes other hormonal issues. As the awareness regarding the side-effect of nafarelin increases among consumers, the sales of nafarelin may take a beating due to this factor in the years to come.

Stuck in a Neck-to-Neck Competition with Other Brands? Request a Custom Report on “Nafarelin Market” here

North America Leads Global Nafarelin Market

The global nafarelin market mainly records its presence across North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa. North America, among these, has occupied the top position due to the increasing research activities, carried by leading players in this market. The U.S. and Canada are the main markets for nafarelin in North America, whereas, the Asia Pacific nafarelin market is led by India, China, and Japan.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Request Report Methodology @ https://www.transparencymarketresearch.com/nafarelin-market.html#enquiry

]]>
Technological Advancement in the Medical Industry is Leading Towards The Rapid Development of Tamiflu (Oseltamivir Phosphate) Market Tue, 13 Aug 2019 15:56:13 +0200 http://comunicati.net/comunicati/aziende/editoria/589473.html http://comunicati.net/comunicati/aziende/editoria/589473.html Researcher Researcher The global tamiflu (oseltamivir phosphate) market is witnessing a continuously changing market dynamics. Oseltamivir is an antiviral medication utilized to prevent and treat influenza A and B. Commercially, it is sold under the brand name Tamiflu. Although the U.S. FDA approved oseltamivir phosphate for the treatment of influenza in human in 1999; however, the first generic version of Tamiflu gained approval in 2016 only.

In this research report, the global tamiflu (oseltamivir phosphate) market has been assessed thoroughly, using the quantitative and qualitative assessment techniques. Further, it has estimated the performance of this market over the period from 2019 to 2027 on the basis of various prominent trends and the market dynamics. The report also offers a detailed assessment of the key segments of this market and each of the regional markets for tamiflu (oseltamivir phosphate) across the world.

Need an Overview of the Report on Tamiflu Market? Ask for the Brochure here

Global Tamiflu (Oseltamivir Phosphate) Market: Notable Developments

The global tamiflu (oseltamivir phosphate) market is not much competitive as there is only player in this market. F. Hoffmann La Roche is the originator of this drug. Gilead Sciences discovered oseltamivir using shikimic acid as the starting point for the synthesis and exclusively licensed their relevant patents to F. Hoffmann La Roche in 1996. Recently Genentech, a sister concern of Roche, announced that the third phase of MINISTONE-2 clinical trial has touched its primary endpoint, showcasing that its new drug, Xofluza (baloxavir marboxil), could be equated to its own blockbuster drug, Tamiflu (oseltamivir). The tests demonstrated that Xofluza was also well-tolerated in kids, suffering with the flu.

In another event, Sanofi entered into an agreement with F. Hoffmann La Roche for exclusive over-the-counter rights to Tamiflu® for the treatment of influenza in the U.S. According to the terms of the agreement, Sanofi will be leading the FDA negotiations for the over-the-counter shift and the subsequent exclusive rights for marketing, scientific engagement, and the distribution of Tamiflu OTC in the country. As of now, Genentech sells Tamiflu in the U.S.

Stuck in a Neck-to-Neck Competition with other Brands? Request a Custom Report on “Tamiflu Market” here

Global Tamiflu (Oseltamivir Phosphate) Market Dynamics

Although, Tamiflu® is a parented property of F. Hoffmann La Roche; other pharmaceutical companies can produce and sell this drug in Thailand, Indonesia, Philippines, and several other Asian countries as the drug is not been patent protected in these nations. The presence of local players has created a competitive environment for Tamiflu in these domestic markets. The dearth of awareness among people in developing regions is also impacting the global tamiflu (oseltamivir phosphate) market negatively.

North America Leads Global Tamiflu (Oseltamivir Phosphate) Market

The global tamiflu (oseltamivir phosphate) market mainly reports its presence across North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa. Among these, North America has acquired the leading position, reason being the only company that officially produces the drug headquartered in the U.S. Roche has continuously been working on research and development of Tamiflu to improve its efficacy, which is supporting the North America tamiflu (oseltamivir phosphate) market remarkably. With no major competitor in sight, this regional market is likely to remain on the top over the next couple of years.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Request Report Methodology @ https://www.transparencymarketresearch.com/tamiflu-oseltamivir-phosphate-market.html#enquiry

]]>
Global Digital Respiratory Devices Market to Extend Generously During the Upcoming years Tue, 13 Aug 2019 15:54:27 +0200 http://comunicati.net/comunicati/aziende/editoria/589470.html http://comunicati.net/comunicati/aziende/editoria/589470.html Researcher Researcher Digital respiratory devices compromises therapeutic and diagnostic devices which are connected to smartphone applications or other data collection modules. These devices are used in the treatment and monitoring of asthma, chronic obstructive pulmonary diseases (COPD), and other respiratory diseases. Digital respiratory devices help to deliver correct dose of the drug and also monitor patient health and treatment outcomes efficiently. These technologically advanced devices enable patient and physician to monitor, record, and track the dose recording during the treatment. Better disease management can be achieved with the help of smart respiratory devices.

Digital Respiratory Devices Market – Competitive Landscape

The global digital respiratory devices market is highly fragmented due to the presence of large number of players. A large number of manufacturers hold prominent market shares in their respective regions. Leading players in the global digital respiratory devices market are Teva Pharmaceutical Industries Ltd., Propeller Health, 3M, AstraZeneca, Glenmark, Adherium Ltd., Pneuma Respiratory, Findair Sp. z o. o, Cohero Health, Inc., and Amiko Digital Health Limited. In December 2018, ResMed acquired Propeller Health. This acquisition enabled the company to strengthen its position in digital health for COPD. In February 2019, Orion entered into partnership agreement with Propeller Health to bring new smart medicines to patients with COPD and asthma. This enabled Propeller Health to expand presence in Europe. These strategies by key players contribute to the growth of the global respiratory devices market. Demand for digital respiratory devices has increased in developed as well as developing markets. Industry players are adopting the practice of appointing third-party distributors to expand market presence. For instance, in August 2018, Pneuma Respiratory, Inc. announced that Haisco Pharmaceutical had agreed to make equity investment in the company. This agreement enabled Haisco Pharmaceutical to distribute Pneuma Respiratory, Inc.’s products in China.

Need an Overview of the Report on Digital Respiratory Devices Market? Ask for the Brochure here

Teva Pharmaceutical Industries Ltd.

Founded in 1901 and headquartered in Petach Tikva, Israel, Teva Pharmaceutical Industries Ltd. is one of the leading players in the market. The generics business is the key strength of the company. It also operates in the specialty medicine and OTC business segments. Teva Pharmaceutical Industries operates globally, with a significant presence in the U.S., Europe, and other parts of the world. It has presence in 60 countries.

AstraZeneca

Incorporated in 1999 and headquartered in Cambridge, the U.K., AstraZeneca is one of the leading biopharmaceutical companies engaged in the design, development, and commercialization of products for therapeutic areas such as respiratory, renal & metabolism, cardiovascular, and oncology. The company has presence in more than 100 countries and its innovative medicines are used by millions of patients across the globe.

Glenmark

Established in 1977 and headquartered in Mumbai, India, Glenmark is one of the leading pharmaceutical organizations. The company have mainly focused on developing new chemical entity and new biological entity. It offers products in therapeutic areas including dermatology, respiratory, and oncology. Glenmark has 16 manufacturing facilities and six research and development centers in five countries.

Stuck in a Neck-to-Neck Competition with other Brands? Request a Custom Report on “Digital Respiratory Devices Market” here

Digital Respiratory Devices Market – Dynamics

Rise in Prevalence of Respiratory Diseases

According to the World Health Organization, in 2016, an estimated 251 million cases of chronic obstructive pulmonary diseases were recorded across the world. Moreover, globally, around 339 million people were affected by asthma in 2018. Furthermore, COPD accounts for more than 3 million deaths across the world each year. Rise in prevalence of asthma, COPD, and other respiratory diseases is likely propel the global market.

New Product Launch and Approval

In December 2018, Teva Pharmaceutical Industries Ltd. received clearance from the Food and Drug Administration for its digital inhaler. In April 2018, Adherium Ltd. received OTC clearance for AstraZeneca’s Symbicort inhaler. In May 2016, Glenmark launched first digital inhaler for COPSD and asthma. Product launch and approval by key players is anticipated to boost the growth of the global digital respiratory devices market.

Request Report Methodology @ https://www.transparencymarketresearch.com/digital-respiratory-devices-market.html#enquiry

]]>
Global Pharmacogenomics Market to reach a market size of $9.9 billion by 2025- KBV Research Tue, 13 Aug 2019 14:42:50 +0200 http://comunicati.net/comunicati/aziende/editoria/589485.html http://comunicati.net/comunicati/aziende/editoria/589485.html KBV Research KBV Research

According to a new report Global Pharmacogenomics Market, published by KBV research, The Global Pharmacogenomics Market size is expected to reach $9.9 billion by 2025, rising at a market growth of 8.8% CAGR during the forecast period.

 

pharmacogenomics-market.jpg

The Hospitals and Clinics market dominated the Global Pharmacogenomics Market by End User in 2018, growing at a CAGR of 8.5 % during the forecast period. The Research Institutions market is expected to witness highest CAGR of 9.1% during (2019-2025).

 

The North America market dominated the Global Infectious Diseases Market by Region in 2018, growing at a CAGR of 9.1 % during the forecast period. The Europe market is expected to witness a CAGR of 9.3% during (2019-2025). Additionally, The Asia Pacific market is expected to witness a CAGR of 11.2% during (2019-2025).

 

The Sequencing market in the Global Pharmacogenomics Market by Technology would grow at a CAGR of 8 % during the forecast period. The Polymerase Chain Reaction market is expected to witness a CAGR of 8.1% during (2019-2025).

 

Full Report: https://www.kbvresearch.com/pharmacogenomics-market/

 

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Abbott Laboratories, Empire Genomics LLC, Illumina, Inc., oneome LLC, Myriad Genetics Inc., Thermo Fisher Scientific, Inc., Teva Pharmaceuticals Industries Ltd., Bayer AG, Opko Health, Inc., and Becton, Dickinson and Company.

 

Global Pharmacogenomics Market Segmentation

 

By Technology

Sequencing

Polymerase Chain Reaction

Electrophoresis

Mass Spectrometry

Microarray

Others

 

By Application

Oncology

Psychiatry

Infectious Diseases

Neurological Diseases

Pain management

Cardiovascular Diseases

Others

 

By End User

Hospitals and Clinics

Research Institutions

Academic Institutes

 

By Geography

 

North America

US

Canada

Mexico

Rest of North America

 

Europe

Germany

UK

France

Russia

Spain

Italy

Rest of Europe

 

Asia Pacific

China

Japan

India

South Korea

Singapore

Malaysia

Rest of Asia Pacific

 

LAMEA

Brazil

Argentina

UAE

Saudi Arabia

South Africa

Nigeria

Rest of LAMEA

 

Companies Profiled

Abbott Laboratories

Empire Genomics LLC

Illumina, Inc.

Oneome LLC

Myriad Genetics Inc.

Thermo Fisher Scientific, Inc.

Teva Pharmaceuticals Industries Ltd.

Bayer AG

Opko Health, Inc.

Becton, Dickinson and Company

 

Unique Offerings from KBV Research

Exhaustive coverage

Highest number of market tables and figures

Subscription based model available

Guaranteed best price

Assured post sales research support with 10% customization free

 

Pharmacogenomics Market Related Reports:

North America Market

Europe Market

Asia Pacific Market

LAMEA Market

 

]]>
Global Conversational Systems Market to reach a market size of $20 billion by 2025- KBV Research Mon, 12 Aug 2019 14:07:07 +0200 http://comunicati.net/comunicati/aziende/editoria/589152.html http://comunicati.net/comunicati/aziende/editoria/589152.html KBV Research KBV Research

According to a new report Global Conversational Systems Market, published by KBV Research, The Global Conversational Systems Market size is expected to reach $20 billion by 2025, rising at a market growth of 28.6% CAGR during the forecast period.

 

conversational-systems-market.jpg

The Customer Support & Personal Assistance market dominated the Global Conversational Systems Market by Application 2018, growing at a CAGR of 27.8 % during the forecast period. The Branding & Advertisement market is expected to witness a CAGR of 28.1% during (2019-2025). Additionally, The Data Privacy & Compliance market is expected to witness highest CAGR of 30.1% during (2019-2025).

 

The Compute Platforms market dominated the Global Conversational Systems Market by Component 2018, growing at a CAGR of 27.5 % during the forecast period. The Solutions market is expected to witness a CAGR of 29.3% during (2019-2025). Additionally, The Services market is expected to witness highest CAGR of 33.8% during (2019-2025).

 

The North America market dominated the Global Retail & Ecommerce Conversational Systems Market by Region 2018, growing at a CAGR of 25.7 % during the forecast period. The Europe market is expected to witness a CAGR of 26.4% during (2019-2025). Additionally, The Asia Pacific market is expected to witness a CAGR of 29.7% during (2019-2025).

 

Full Report: https://www.kbvresearch.com/conversational-systems-market/

 

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Google Inc., Microsoft Corporation, IBM Corporation, Amazon.com, Inc., Oracle Corporation, SAP SE, Nuance Communications, Inc., Inbenta Technologies, Inc., Conversica, Inc., and Baidu, Inc.

 

Global Conversational Systems Market Segmentation

 

By Component

Compute Platforms

Solutions

Services

 

By Type

Text Assistant

Voice Assistant

Others

 

By Application

Customer Support & Personal Assistance

Branding & Advertisement

Data Privacy & Compliance

Others

 

By End User

BFSI

Retail & Ecommerce

Telecom

Media & Entertainment

Healthcare & Life sciences

Travel & Hospitality

Others

 

By Geography

 

North America

US

Canada

Mexico

Rest of North America

 

Europe

Germany

UK

France

Russia

Spain

Italy

Rest of Europe

 

Asia Pacific

China

Japan

India

South Korea

Singapore

Malaysia

Rest of Asia Pacific

 

LAMEA

Brazil

Argentina

UAE

Saudi Arabia

South Africa

Nigeria

Rest of LAMEA

 

Companies Profiled

Google Inc.

Microsoft Corporation

IBM Corporation

Amazon.com, Inc.

Oracle Corporation

SAP SE

Nuance Communications, Inc.

Inbenta Technologies, Inc.

Conversica, Inc.

Baidu, Inc.

 

Unique Offerings from KBV Research

Exhaustive coverage

Highest number of market tables and figures

Subscription based model available

Guaranteed best price

Assured post sales research support with 10% customization free

 

Conversational Systems Market Related Reports:

North America Market

Europe Market

Asia Pacific Market

LAMEA Market

 

]]>
Global Air Humidifier Market to reach a market size of $3.8 billion by 2025- KBV Research Fri, 09 Aug 2019 14:20:50 +0200 http://comunicati.net/comunicati/aziende/editoria/588728.html http://comunicati.net/comunicati/aziende/editoria/588728.html KBV Research KBV Research

According to a new report Global Air Humidifier Market, published by KBV research, The Global Air Humidifier Market size is expected to reach $3.8 billion by 2025, rising at a market growth of 4.1% CAGR during the forecast period.

 

air-humidifier-market.jpg

The Commercial market in the Global Air Humidifier Market by Application would grow at a CAGR of 5.4 % during the forecast period. The Industrial market is expected to witness a CAGR of 5.3% during (2019-2025).

 

The Vaporizers market dominated the Global Air Humidifier Market by Type in 2018growing at a CAGR of 4.8 % during the forecast period. The Impeller Humidifier market is expected to witness a CAGR of 5.5% during (2019-2025).

 

The North America market dominated the Global Air Humidifier Market by Region in 2018, growing at a CAGR of 4.8 % during the forecast period. The Europe market is expected to witness a CAGR of 4% during (2019-2025). Additionally, The Asia Pacific market is expected to witness a CAGR of 6.4% during (2019-2025).

 

Full Report: https://www.kbvresearch.com/air-humidifier-market/

 

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Koninklijke Philips N.V., Whirlpool Corporation, United Technologies Corporation, Mitsubishi Heavy Industries Ltd., The Procter and Gamble Company, Airmatic, Inc., LG Corporation, CondAir Group AG and Armstrong International, Inc.

 

Global Air Humidifier Market Segmentation

 

By Application

Commercial

Industrial

Industrial

 

By Type

Vaporizers

Impeller Humidifier

Ultrasonic Humidifier

Evaporative Humidifiers

 

By Geography

 

North America

US

Canada

Mexico

Rest of North America

 

Europe

Germany

UK

France

Russia

Spain

Italy

Rest of Europe

 

Asia Pacific

China

Japan

India

South Korea

Singapore

Malaysia

Rest of Asia Pacific

 

LAMEA

Brazil

Argentina

UAE

Saudi Arabia

South Africa

Nigeria

Rest of LAMEA

 

Companies Profiled

Koninklijke Philips N.V.

Whirlpool Corporation

United Technologies Corporation

Mitsubishi Heavy Industries Ltd.

The Procter and Gamble Company

Airmatic, Inc.

LG Corporation

CondAir Group AG

Armstrong International, Inc.

 

Unique Offerings from KBV Research

Exhaustive coverage

Highest number of market tables and figures

Subscription based model available

Guaranteed best price

Assured post sales research support with 10% customization free

 

Air Humidifier Market Related Reports:

North Market

Europe Market

Asia Pacific Market

LAMEA Market

 

]]>